Japan, June 25 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'MICE EXPRESSING HUMANIZED T CELL CO-RECEPTOR.' Other related details are as follows:

Application Number: JP,2023-191033

Category (FI): C12N15/12,C07K14/705,A61P37/02,A61K40/11,A01K67/027,C12N5/0783,C12N5/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Nov. 8, 2023

Publication Date: Dec. 28, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....